DAX19.146 +0,7%ESt504.756 +0,6%MSCIW3.751 -0,1%Dow43.870 +1,1%Nas18.972 ±0,0%Bitcoin94.570 +0,5%Euro1,0470 -0,1%Öl74,24 -0,2%Gold2.693 +0,9%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 MicroStrategy 722713 Tesla A1CX3T Bayer BAY001 Rheinmetall 703000 Porsche PAG911 Volkswagen (VW) vz. 766403 Coinbase A2QP7J Amazon 906866 Mercedes-Benz Group (ex Daimler) 710000 Palantir A2QA4J Siemens Energy ENER6Y Deutsche Telekom 555750 NEL ASA A0B733 EVOTEC 566480
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX vorbörslich leicht positiv -- Asiens Börsen uneinheitlich - China-Börsen scheren nach unten aus -- Chef der US-Börsenaufsicht tritt mit Trumps Vereidigung ab
Top News
Wirecard-Aktionär will Schadenersatz - Musterprozess beginnt Wirecard-Aktionär will Schadenersatz - Musterprozess beginnt
UBS senkt Ziel für RWE auf 45 Euro UBS senkt Ziel für RWE auf 45 Euro
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Accelerate Diagnostics Aktie

NeuKaufenVerkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone

WKNA1KA68

ISINUS00430H1023

SymbolAXDX

Accelerate Diagnostics Aktien News

DatumMeistgelesen
ZacksAccelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates
PR NewswireAccelerate Diagnostics Reports Third Quarter 2024 Financial Results
PR NewswireAccelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results
ZacksAccelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
PR NewswireAccelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
ZacksAccelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial
ZacksAccelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
PR NewswireAccelerate Diagnostics Reports Second Quarter 2024 Financial Results
PR NewswireAccelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial
PR NewswireAccelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results
ZacksAccelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates
PR NewswireAccelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
ZacksWill Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know
PR NewswireAccelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
ZacksAccelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
BenzingaRecap: Accelerate Diagnostics Q4 Earnings
PR NewswireAccelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
PR NewswireAccelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
BenzingaWhy Accelerate Diagnostics (AXDX) Stock Is Down 38%
BenzingaWhy Accelerate Diagnostics (AXDX) Stock Hit A New 52-Week Low Today
PR NewswireAccelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
ZacksAccelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics
PR NewswireAccelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®
ZacksAccelerate Diagnostics (AXDX) Loses -25.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PR NewswireAccelerate Diagnostics Reports Third Quarter 2023 Results
PR NewswireAccelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.
PR NewswireAccelerate Diagnostics Reports Second Quarter 2023 Financial Results
PR NewswireAccelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results
PR NewswireAccelerate Diagnostics Announces 1-for-10 Reverse Stock Split
PR NewswireAccelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave
PR NewswireAccelerate Diagnostics Reports First Quarter 2023 Financial Results
PR NewswireAccelerate Diagnostics scheduled call to review 2023 first quarter results
PR NewswireAccelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
PR NewswireAccelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results
PR NewswireAccelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement
PR NewswireAccelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors
PR NewswireAccelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kit
PR NewswireAccelerate Diagnostics Reports Third Quarter 2022 Financial Results
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDX

Accelerate Diagnostics News

Accelerate Diagnostics News: auf dieser Seite finden Sie alle Accelerate Diagnostics News und Nachrichten zur Accelerate Diagnostics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Accelerate Diagnostics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Accelerate Diagnostics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.